...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Pfizer seems like a good fit for a BP deal

Shenzhen Hepalink's all-time low still equates to approximately $3 Billion Canadian in Market Capitalization.

 

CashCN¥2.27b   ($423M CAN)

EquityCN¥12.50b ($2.4B CAN)

Total liabilitiesCN¥7.62b   ($1.4B CAN)

Total assetsCN¥20.12b ($3.8B CAN)

Book value (7.18B CNY) ~ ($1.4B CAN) 

Working Capital (5.21B CNY) ~ ($1.0B CAN)

Resverlogix's market cap sits at $19 Million Canadian. And the last time RVX received investment money was in May 2023. If it weren't for Zenith CC I don't know where RVX would be right now.

Nothing is perfect. But it may not be all that bad if we're governed by HL!

 

Koo

 

Share
New Message
Please login to post a reply